Updated:
Foundation for Barnes-Jewish Hospital
The Foundation for Barnes-Jewish Hospital was established in 1996 as the philanthropic engine of BJC HealthCare, the region's dominant hospital system.
Foundation for Barnes-Jewish Hospital
The Foundation for Barnes-Jewish Hospital was established in 1996 as the philanthropic engine of BJC HealthCare, the region's dominant hospital system. Chairman Mahendra R. Gupta, former dean of Washington University's Olin Business School, governs a board that allocates charitable gifts toward research grants, nursing scholarships, and capital projects across the Barnes-Jewish campus. Its primary research partner is the Washington University School of Medicine, which receives grants to fund clinical trials and translational science. The Foundation deploys capital across three distinct lanes. First, it funds early-stage biomedical research — predominantly Seed through Start-up-stage ventures — often alongside Washington University's technology-transfer office. Second, it owns and develops physical assets, including the Institute of Health Expansion on the university's medical campus and Evelyn's House, a residential hospice facility in Creve Coeur. Third, its endowment portfolio includes fund commitments and co-investments with institutional partners. Confirmed portfolio exposure includes Bloomberg Philanthropies, which co-funded the BELIEVE Academy healthcare-education initiative. Stage coverage leans toward Venture (General) and Fund of Funds allocations, with no disclosed direct-late-stage buyouts. The Foundation maintains an 11-person board and operates from leased headquarters at 1001 Highlands Plaza Drive West in St. Louis. Its investment committee oversees a pooled endowment — Altss estimates the portfolio at roughly $861 million — that supports named vehicles including the Cancer Frontier Fund, which backs Siteman Cancer Center research, and the Emergency Compassion Fund for patient-assistance grants. Board member Thomas Hillman sits on the YPO Gold International Board, connecting the Foundation to the young-president network's capital and deal flow. The Foundation does not publicly disclose its investment staff headcount or a dedicated CIO role. Unlike peer hospital foundations that outsource investment management, the Foundation for Barnes-Jewish Hospital appears to function as an operating endowment with in-house portfolio oversight and direct co-investment capability. Its dual mandate — funding university research while also developing real assets on the medical campus — creates a sourcing flywheel: clinical grants generate deal visibility, and campus-owned facilities generate long-duration income streams that offset the portfolio's venture exposure. No succession plan for the chairman role has been publicly disclosed.
General information
Firm type
Endowment / Foundation
Year founded
1996
Location
Region
North America
Country
United States
City
Saint Louis
Corporate office
1001 Highlands Plaza Drive West, Suite 140, St. Louis, MO 63110, United States
Principals
Mahendra R. Gupta
Chairman of the Board
Sector focus
Frequently asked questions
Who runs investment decisions at the Foundation for Barnes-Jewish Hospital?
The Foundation does not publicly name a chief investment officer. Its 11-member board, chaired by Mahendra R. Gupta, oversees the investment committee and portfolio strategy. The board includes members with connections to YPO Gold, suggesting some peer-network deal flow, but day-to-day investment-staff identities and reporting structures remain undisclosed.
How is the Foundation related to Barnes-Jewish Hospital and BJC HealthCare?
The Foundation is a 501(c)(3) non-profit that serves as the primary charitable fundraising and grantmaking entity for Barnes-Jewish Hospital. BJC HealthCare is the Foundation's sole corporate member and parent organization. The Foundation funds hospital programs, nursing scholarships, and capital projects — but operates with its own board and investment portfolio.
Does the Foundation have a single investment portfolio, or are there separate pools?
The Foundation maintains a core endowment portfolio that supports its operations and grantmaking, but it also stewards several named sub-vehicles. The Cancer Frontier Fund directs donations exclusively to Siteman Cancer Center research, and the Emergency Compassion Fund provides patient-assistance grants. The Foundation owns physical assets — including a hospice and a medical-campus expansion — held outside the liquid portfolio.
What investment stages does the Foundation typically target?
The Foundation's investment strategy spans Early Stage, Seed, Start-up, and Expansion/Late Stage, with a Fund of Funds component. Its life-science venture activity tends toward early-stage companies emerging from Washington University research, while its real-asset holdings generate longer-term, lower-volatility returns to balance the venture exposure.
Which sectors does the Foundation explicitly avoid?
Public disclosures do not identify excluded sectors. Given its hospital-affiliated mission, the portfolio is unlikely to invest in direct competitors to Barnes-Jewish or in industries that pose reputational risk to a healthcare endowment — but no formal exclusion policy has been published.
Does the Foundation co-invest alongside external institutional partners?
Yes. The Foundation has co-invested with Bloomberg Philanthropies on the BELIEVE Academy healthcare-education initiative. Its endowment also includes fund commitments where co-investment rights are typical, though the Foundation does not disclose specific GP relationships or co-investment deal terms.
Where does the Foundation's underlying capital come from?
Capital originates from charitable donations — individual gifts, corporate sponsorships, and fundraising events like the Illumination Gala and Pedal the Cause. The Foundation does not distribute a spend rule publicly, so the proportion of grantmaking funded by endowment returns versus new donations is not known.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: